These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3584474)

  • 1. Gangliosides shed by tumor cells enhance tumor formation in mice.
    Ladisch S; Kitada S; Hays EF
    J Clin Invest; 1987 Jun; 79(6):1879-82. PubMed ID: 3584474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by YAC-1 lymphoma: role of shed gangliosides.
    Lu P; Sharom FJ
    Cell Immunol; 1996 Oct; 173(1):22-32. PubMed ID: 8871598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine leukemia. Proposed role for gangliosides in immune suppression.
    Krishnaraj R; Lengle EE; Kemp RG
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):89-98. PubMed ID: 6211363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor gangliosides inhibit the tumor-specific immune response.
    McKallip R; Li R; Ladisch S
    J Immunol; 1999 Oct; 163(7):3718-26. PubMed ID: 10490967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides.
    Ladisch S; Gillard B; Wong C; Ulsh L
    Cancer Res; 1983 Aug; 43(8):3808-13. PubMed ID: 6861145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host reactions and the viral induction of mouse lymphoma.
    Hays EF
    Cancer Res; 1972 Feb; 32(2):270-5. PubMed ID: 4400464
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure of a new disialoganglioside GD1c from spontaneous murine thymoma.
    Bartoszewicz Z; KoĊ›cielak J; Pacuszka T
    Carbohydr Res; 1986 Aug; 151():77-88. PubMed ID: 3094941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice.
    Yetter RA; Morse HC
    J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin.
    Brandchaft PB; Boone CW
    J Immunol; 1974 Jul; 113(1):94-102. PubMed ID: 4364955
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeling and isolation of Thy-1 active glycolipids from murine brain and lymphoma cell lines.
    Kato KP; Wang TJ; Esselman WJ
    J Immunol; 1979 Nov; 123(5):1977-84. PubMed ID: 90698
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure to detect anti-group-specific murine leukemia virus activity in tetraparental AKR-CBA chimeras.
    Barnes RD; Tuffrey MA; Bourne RC
    Cancer Res; 1975 Oct; 35(10):2699-703. PubMed ID: 168964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SL12 murine T-lymphoma: a new model for tumor cell heterogeneity.
    MacLeod CL; Weinroth SE; Streifinger C; Glaser SM; Hays EF
    J Natl Cancer Inst; 1985 Apr; 74(4):875-82. PubMed ID: 3872958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel form of GD1c ganglioside IV3 (NeuAc alpha 2-8 NeuGc)Gg4Cer from murine X-ray induced thymoma.
    Pacuszka T; Antoniewicz J
    Acta Biochim Pol; 1988; 35(4):387-93. PubMed ID: 3150198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Bekesi JG; Roboz JP; Zimmerman E; Holland JF
    Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 18. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of T-cell lymphoma in AKR/J mice.
    Peled A; Haran-Ghera N
    Leukemia; 1988 Dec; 2(12 Suppl):125S-131S. PubMed ID: 2848990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
    Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
    Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.